Contracting Office Address:

Department of Health and Human Services, Center for Disease Control and Prevention (CDC) Procurement and Grants (PGO), Acquisition and Assistance Branch 1, 2920 Brandywine Road, MS E-15, Atlanta, GA 30341-5539

NOTICE OF INTENT TO SOLE SOURCE: CDC announces its intention to negotiate and issue a sole source award for the purchase of Non-Human Primate Cytokine Kits with Millipore Corportation

The anticipated delivery dates will be August 15, 2012. Millipore Corporation is the only identified source that can provide the Cytokine Kits within the timeframe deemed necessary. CDC intends to negotiate this requirement under the authority of FAR 13.106-1(b)(1). The sole source procurement will be awarded as a simplified acquisition in accordance with FAR Part 12 & FAR Subpart 13 procedures. The vendor will be responsible for the following supplying the following types for Non-Human Primate Cytokine Kits:

23 - Non-Human Primate Cytokine Kits, PRE
11 - Human Primate Cytokine Kits, PREMIXED 26 Ple
4 - High Sensitivty Human Cytokine PREMIXED
6 - C-REACT PROT (HU) E:ISA-96 WELLS
6 - Lincokit Catalog ID.HCVD2-67BK-01.Human
4 - Mscrn-HA MCE .45um Clear Ster 10/pk
9 - Guava ViaCount Reagent (100 tests)
3 - Guava Check Kit
3 - Guava Flow Cell (PCA/EasyCyte Mini)
2 - Guava Auto CD4/CD4% Reagent Kit
6 - Milliplex Catalog ID.MPKPRCYTO-40k-12.No
Analytes for the MPXPRCYTO-40K-12: MIP-1a; MIP-1b; MCP-1; TNF-a; IFNg; IL-1b; GM-CSF; G-CSF; IL-12/23(p40); IL-6; IL-8; IL-18; IL-1ra; Analyte for the HCVD2067BK-01 is CRP

This notice of intent is not a request for competitive proposals. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a capability statement demonstrating their abilities to meet this requirement. All responses should be received by August 2, 2012 at 2PM Eastern Standard Time. All responses must be in writing and can be sent via email to [email protected]. No phone calls will be accepted.